av/enochian-biosciences--big.svg

NASDAQ:ENOB

Enochian Biosciences, Inc.

  • Stock

USD

Last Close

0.70

04/08 19:58

Market Cap

45.38M

Beta: 1.09

Volume Today

87.29K

Avg: 57.04K

PE Ratio

0.00

PFCF: −3.61

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
net income
-10.41M
-
-6.58M
36.78%
-6.20M
5.79%
-90.24M
1,355.09%
-7.70M
91.47%
-4.33M
-
-23.20M
435.97%
-9.18M
60.45%
-4.53M
50.64%
-17.02M
275.89%
depreciation and amortization
100.39K
-
101.16K
0.77%
101.80K
0.63%
28.33K
72.17%
28.40K
0.24%
28.24K
-
28.01K
0.83%
27.26K
2.67%
33.16K
21.65%
30.30K
8.62%
deferred income tax
stock based compensation
1.08M
-
612.88K
43.05%
983.83K
60.52%
999.23K
1.57%
1.86M
86.30%
change in working capital
-592.00K
-
-423.51K
28.46%
584.03K
237.90%
1.85M
216.18%
3.33M
80.40%
-158.56K
-
982.99K
719.94%
628.95K
36.02%
153.46K
75.60%
4.33M
2,724.09%
accounts receivables
1.64K
-
-46
-
-3.99K
8,569.57%
inventory
accounts payables
227.31K
-
-381.12K
267.67%
320.27K
184.03%
914.85K
185.65%
3.28M
258.62%
-83.87K
-
825.47K
1,084.21%
124.30K
84.94%
156.79K
26.14%
1.83M
1,066.60%
other working capital
-820.95K
-
-42.39K
94.84%
263.76K
722.22%
931.78K
253.27%
54.36K
94.17%
149
99.73%
148
0.67%
16.24K
-
-1.65K
110.17%
-1.65K
0.06%
other non cash items
5.60M
-
2.87M
48.77%
2.61M
8.86%
84.45M
3,130.49%
-1.70M
102.01%
74.62K
-
352.76K
372.73%
4.64M
1,214.72%
196.65K
95.76%
-256.11K
230.23%
net cash provided by operating activities
-5.28M
-
-4.62M
12.44%
-2.78M
39.73%
-3.05M
9.54%
-2.82M
7.55%
-3.31M
-
-2.26M
31.63%
-2.78M
22.80%
-3.15M
13.30%
-2.63M
16.30%
investments in property plant and equipment
-5.16K
-
-23.63K
-
-6.14K
-
-5.29K
-
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
-1.06M
-
-15.75K
98.51%
net cash used for investing activites
-5.16K
-
-6.14K
-
-1.06M
17,126.43%
-57.33K
94.58%
-91.60K
59.76%
debt repayment
-227.60K
-
-222.17K
2.39%
-111.08K
50.00%
-466.63K
-
-280.77K
39.83%
-562.82K
100.45%
-2.50M
345.08%
-2.29M
8.70%
common stock issued
130K
-
4.91K
-
1.63M
32,975.51%
2.48M
-
1.53M
38.43%
2M
30.82%
1M
-
common stock repurchased
dividends paid
other financing activites
3.05M
-
451.70K
85.18%
1.18M
160.43%
net cash used provided by financing activities
2.95M
-
229.53K
92.22%
1.07M
366.25%
1.63M
51.84%
2.11M
-
1.25M
40.81%
2.56M
105.35%
2.85M
11.08%
2.64M
7.23%
effect of forex changes on cash
28.30K
-
-53.86K
290.27%
-78.74K
46.20%
77.60K
198.55%
153.08K
97.27%
net change in cash
-5.28M
-
-1.67M
68.40%
-2.56M
53.19%
-1.98M
22.61%
-1.20M
39.35%
-1.17M
-
-1.07M
8.31%
-1.35M
25.84%
-279.49K
79.31%
68.72K
124.59%
cash at beginning of period
20.66M
-
15.38M
25.57%
13.71M
10.85%
11.15M
18.65%
9.17M
17.75%
4.12M
-
2.95M
28.43%
1.87M
36.42%
523.47K
72.07%
243.98K
53.39%
cash at end of period
15.38M
-
13.71M
10.85%
11.15M
18.65%
9.17M
17.75%
7.97M
13.09%
2.95M
-
1.87M
36.42%
523.47K
72.07%
243.98K
53.39%
312.70K
28.17%
operating cash flow
-5.28M
-
-4.62M
12.44%
-2.78M
39.73%
-3.05M
9.54%
-2.82M
7.55%
-3.31M
-
-2.26M
31.63%
-2.78M
22.80%
-3.15M
13.30%
-2.63M
16.30%
capital expenditure
-5.16K
-
-23.63K
-
-6.14K
-
-5.29K
-
free cash flow
-5.28M
-
-4.62M
12.52%
-2.78M
39.73%
-3.05M
9.54%
-2.82M
7.55%
-23.63K
99.16%
-3.31M
13,896.50%
-2.27M
31.44%
-2.78M
22.47%
-3.15M
13.30%
-2.64M
16.13%

All numbers in USD (except ratios and percentages)